• INTRODUCTION OF GUESTS OF HONOR: John A. Ridge, MD, PhD & Bhuvanesh Singh, MD, PhD


• AHNS Annual Meeting 2010 Las Vegas, Nevada - Program

Scientific Program

PLENARY SESSION #1: CLINICAL
Moderators: Jeffrey Scott Magnuson, MD, Andy Trotti, MD and Bevan Yueh, MD

• S001: QUALITY AND PERFORMANCE INDICATORS FOR AN ACADEMIC HEAD AND NECK SURGICAL ONCOLOGY DEPARTMENT: Randal S Weber, MD


• S002: TRANSORAL ROBOTIC SURGERY (TORS): A MULTICENTER STUDY TO ASSESS SAFETY,
  FEASIBILITY AND EFFICACY. Gregory S Weinstein MD FACS, Professor and Vice Chairman
  


• S003: EVALUATION OF GRADE 3/4 MUCOSITIS AND DYSPHAGIA FOR THREE DIFFERENT
  RADIOTHERAPY REGIMENS, WITH AND WITHOUT CETUXIMAB, IN LOCOREGIONALLY ADVANCED HEAD
  AND NECK CANCER. J A Bonner, MD


• AHNS Commentary on Cetuximab Trial: Discussant: Andy Trotti, MD

JOHN J. CONLEY LECTURE

• "Cancer Clinical Trials - The Engine for Progress" Robert L. Comis, MD

CLINICAL POSTER DISCUSSION

• POSTER DISCUSSION: Moderator: Gady Har-El, MD

SCIENTIFIC SESSION #1
Moderators: Elizabeth A. Blair, MD, Snehal Patel, MD and Erich M. Sturgis, MD

• S004: FIRST REPORT OF VALIDATION OF THE SYDNEY SWALLOW QUESTIONNAIRE (SSQ) IN A HEAD AND NECK CANCER POPULATION: Raghav Dwivedi, MRCS DOHNS MS


• S005: HEAD AND NECK CANCER PATIENTS REFERRED TO A TERTIARY CENTER AFTER PRIOR TREATMENT: COMPLIANCE WITH OR DEVIATION FROM NATIONAL COMPREHENSIVE CANCER NETWORK TREATMENT GUIDELINES. Carol M Lewis, MD MPH


• S006: DISPARITIES IN HEAD AND NECK CANCER TREATMENT BASED ON AGE. Alexander Langerman, MD


• S007: SALVAGE SURGERY AFTER ORGAN PRESERVATION REGIMENS: Rachel M Brock


• S008: IMPACT OF TIME INTERVAL FROM BIOPSY TO START OF TREATMENT: Gregory J Kubicek, MD


• S009: MANAGEMENT OF EARLY T-STAGE TONSILLAR CARCINOMAS - RETROSPECTIVE COMPARISON
  OF RADICAL TONSILLECTOMY VERSUS RADIATION FROM A SINGLE INSTITUTION. Eric D Lamarre, MD

PANEL: OPTIMAL ADJUVANT TREATMENT FOR HIGH-RISK ORAL CANCER
Panel Moderator: Bhuvanesh Singh, MD, PhD

• Overview of Post-Operative Adjuvant Therapy for Head and Neck Cancer: Arlene A. Forastiere, MD


• EORTC 22931/ RTOG 9501: Cases

AHNS BUSINESS MEETING FOR MEMBERS

• Treasurers Report To MembershipApril 2010 Las Vegas NV: Mark K Wax MD

COMBINED OTOLARYNGOLOGY SPRING MEETING 2010

• MicroRNA-21 Specific Targets in Head and Neck Squamous Cell Carcinoma: Wojciech K. Mydlarz, MD

SCIENTIFIC SESSION #2
Moderators: Claudio R. Cernea, MD, David Kutler, MD and Kepal N. Patel, MD

• S010: POSTOPERATIVE RADIOTHERAPY IN MUCOSAL MELANOMA OF THE HEAD AND NECK. A FRENCH
  GETTEC MULTICENTRIC STUDY. Adil BENLYAZID, MD


• S011: COMPARTMENTAL SURGERY IN TONGUE TUMORS: LONG TERM ONCOLOGIC EVALUATION OF A NEW SURGICAL TECHNIQUE VS. CONVENTIONAL DEMOLITIVE TONGUE SURGERY. A FOURTEEN-YEAR CLINICAL EXPERIENCE: Luca Calabrese, MD


• S012: TPF INDUCTION THERAPY WITH RADIOIMMUNOCHEMOTHERAPY FOR THE TREATMENT OF HEAD & NECK CANCER: Wolf Oliver Jordan


• S013: TARGETING CK2 BY SMALL MOLECULE INHIBITOR DMAT MODULATES NF-KAPPAB AND TP53 SIGNALING, SURVIVAL AND MIGRATION IN HEAD AND NECK CANCER: Vishnu R Kannabiran, BS


• S015: AKT PHOSPHORYLATION AS A MARKER OF RESISTANCE TO ZD6474 (VANDETANIB) IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: Genevieve A Andrews

JATIN P. SHAH SYMPOSIUM ON CLINICAL CONTROVERSIES IN HEAD AND NECK SURGERY
UPDATE OF CLINICAL TRIALS IN HEAD & NECK ONCOLOGY
Panel Moderator: Gregory T. Wolf, MD

• Update of RTOG 91-11: Arlene A. Forastiere, MD


• European Organ Preservation Trials: Jan B. Vermorken, MD, PhD

SCIENTIFIC SESSION #3 - RECONSTRUCTION
Moderators: Gerry F. Funk, MD, Neal D. Futran, MD, DMD and Derrick Lin, MD

• S016: A BLOOD TRANSFUSION PREDICTION MODEL IN PATIENTS UNDERGOING MAJOR HEAD & NECK SURGERY INVOLVING FREE FLAP RECONSTRUCTION: Manish D Shah, MD MPhil FRCSC


• S017: A CLASSIFICATION SYSTEM FOR RECONSTRUCTION OF VERTICAL HEMIPHARYNGOLARYNGECTOMY FOR HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA: Min-Sik Kim, MD PhD,


• S018: THE NATURE AND EXTENT OF BODY IMAGE CONCERNS AMONG SURGICALLY TREATED PATIENTS WITH HEAD AND NECK CANCER: NEW FINDINGS TO PROMOTE IMPROVED PSYCHOSOCIAL CARE: Michelle C Fingeret, PhD


• S019: SUBMENTAL FLAP VERSUS RADIAL FOREARM FLAP FOR ORAL CAVITY RECONSTRUCTION: COMPARISON OF OUTCOMES: Urjeet A Patel, MD

PANEL: NEW HORIZONS IN HEAD AND NECK RECONSTRUCTION
Panel Moderator: Joseph J. Disa, MD
Panelists: Matthew M. Hanasono, MD, Eben L. Rosenthal, MD and Mark K. Wax, MD

• Head and Neck Reconstruction Panel

SCIENTIFIC SESSION #4
Moderators: Sandeep Samant, MS, Richard V. Smith, MD and Richard J. Wong, MD

• S020: LOCAL RESPONSE TO CHEMORADIOTHERAPY FOR T4 LARYNGEAL/HYPOPHARYNGEAL CARCINOMA WITH CARTILAGE INVASION: Lori K Howell, MD


• S021: DETERMINANTS OF LONG-TERM SPEECH AND SWALLOWING OUTCOMES FOLLOWING CHEMORADIOTHERAPY FOR LOCOREGIONALLY ADVANCED HEAD AND NECK CANCER: K W Mouw, PhD


• S022: RESIDUAL DISEASE IN POST-CHEMORADIOTHERAPY NECK DISSECTIONS FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: DOES IT AFFECT PROGNOSIS? Hilliary White, MD


• S023: RETROSPECTIVE ANALYSIS OF MINOR SALIVARY GLAND CARCINOMAS OF THE OROPHARYNX AND FACTORS PREDICTIVE OF OUTCOME: N Gopalakrishna Iyer, MD PhD


• S024: THE INCIDENCE AND OUTCOME OF HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS WITH SUSPICIOUS PULMONARY FINDINGS ON PET/CT: Bradley A Schiff, MD


• S025: INDUCTION CHEMOTHERAPY FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE PARANASAL SINUSES: Ehab Y Hanna, MD

Scientific Program

PLENARY SESSION #2: BASIC SCIENCE
Moderators: Carol R. Bradford, MD, Joseph A. Califano, MD, Robert L. Ferris, MD, PhD and James Rocco, MD, PhD

• S026: CD40 IS REQUIRED FOR AN IMMUNE MEDIATED CLEARANCE OF HPV POSITIVE HEAD AND NECK CANCER. William C Spanos, MD


• S027: VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) IS IMPORTANT IN THE DEVELOPMENT AND METASTASIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA: Rachel L Chard, BA


• S028: SIGNIFICANCE OF CIRCULATING TUMOR CELLS IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. Kris R Jatana, MD


• S029: ENHANCED INVASIVE AND METASTATIC POTENTIAL OF CANCER STEM CELLS IN HEAD & NECK SQUAMOUS CELL CARCINOMA. Samantha J Davis, BS

BASIC SCIENCE POSTER DISCUSSION
Moderators: Stephen Y. Lai, MD, PhD

HAYES MARTIN LECTURE "Pathogenetic Stratification of Salivary Gland Malignancies: Promise and Potential"
Adel El-Naggar, MD, PhD, Professor of Pathology and Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Texas; Editor-in-Chief, Head and Neck Oncology

AHNS AWARDS CEREMONY
Presented by: Cherie-Ann O. Nathan, MD and Marilene B. Wang, MD

INTRODUCTION OF THE AHNS PRESIDENT
Introduction by David W. Eisele, MD, AHNS President-Elect

AHNS PRESIDENTIAL ADDRESS AND PRESIDENTIAL HONORS
"We Show Pictures, They Show Curves"
John A. Ridge, MD, PhD, Chief of Head & Neck Surgery, Fox Chase Cancer Center, Philadelphia, PA

SCIENTIFIC SESSION #5
Moderators: Michael Kupferman, MD, Ellie Maghami, MD, Jorge Pinho, MD and David L. Schwartz, MD

• S030: RETROSPECTIVE ANALYSIS OF OUTCOME IN PATIENTS WITH ORAL PREMALIGNANT LESIONS: THE RISK FOR ORAL CANCER DEVELOPMENT. Vanda M Stepanek, MD PhD


• S031: FLUORESCENT SPECTROSCOPY FOR NON-INVASIVE EARLY DIAGNOSIS OF ORAL MUCOSAL MALIGNANT AND POTENTIAL MALIGNANT LESIONS. Pankaj Chaturvedi, FACS FAIS FICS MNAMS


• S032: ORAL SQUAMOUS CELL CARCINOMA: PREDICTING PROGNOSIS FOLLOWING RECURRENCE.
  Ardalan Ebrahimi, Dr


• S033: TARGETING A TREATMENT-RESISTANT, MESENCHYMAL-LIKE SUBPOPULATION WITHIN HEAD
  AND NECK SQUAMOUS CELL CARCINOMAS. Devraj Basu, MD PhD


• S034: INTRAVASCULAR HUMAN SALIVARY CELL DELIVERY TO TREAT SALIVARY CELL LOSS IN A
  RODENT MODEL. Millie Surati, MD


• S035: SENSITIZATION OF HEAD AND NECK CANCER TO CISPLATIN THROUGH THE INHIBITION OF STAT3. Waleed M Abuzeid, MD

SCIENTIFIC SESSION #6
Moderators: Terry A. Day, MD, David Goldenberg, MD and Christine G. Gourin, MD

• S036: DECISION MAKING FOR THE EXTENT OF THYROIDECTOMY IN PATIENTS WITH ATYPICAL CYTOLOGY. Manish D Shah, MD MPhil FRCSC


• S037: SURGICAL PRACTICE PATTERNS IN THE MANAGEMENT OF PAPILLARY THYROID MICROCARCINOMA. Arthur W Wu, MD


• S038: VOLUME-BASED TRENDS IN THYROID SURGERY. Christine G Gourin, MD


• S039: PROPHYLACTIC CENTRAL LYMPH NODE DISSECTION FOR CLINICALLY NODE-NEGATIVE PAPILLARY THYROID MICROCARCINOMA: ITS IMPACT ON POSTOPERATIVE THYROGLOBULIN LEVEL, RECURRENCES AND COMPLICATIONS. Yoon Kyoung So, MD


• S040: ROUTINE PARATHYROID LOCALIZATION WITH 4-D COMPUTED TOMOGRAPHY/ULTRASOUND IN PATIENTS WITH HYPERPARATHYROIDISM: Rachel A Moquete, BA


• S041: INTRAOPERATIVE PARATHYROID HORMONE MONITORING IN PARATHYROIDECTOMY; IS IT MANDATORY? Aviram Mizrachi, MD

PANEL:
ROLE OF SURGERY IN LABORATORY THYROID CANCER – SUPPORTED BY CLINICAL DATA?
Panel Moderator: Ashok R. Shaha, MD
Panelists: Quan-Yang Duh, MD, Bryan McIver, MBChB, PhD,
Christopher R. McHenry, MD and Lisa A. Orloff, MD

NCCN GUIDELINES DISCUSSION PLATINUM ROOM
Panel Moderator: David G. Pfister, MD "NCCN Guidelines Development Process"

SCIENTIFIC SESSION #7
Moderators: Floyd “Chris” Holsinger, MD, Cherie-Ann O. Nathan, MD and Theodoros N. Teknos, MD

• S042: INCREASED TOLL-LIKE RECEPTOR EXPRESSION AND ACTIVITY IN REGULATORY T CELLS IN PATIENTS WITH HEAD AND NECK CANCER: Christoph Bergmann, MD PhD


• S043: CELLULAR IMMUNITY CORRELATES WIHT HUMAN PAPILLOMA VIRUS-16 (HPV-16) STATUS AND OUTCOME IN PATIENTS WITH ADVANCED OROPHARYNGEAL CANCER: Derrick Wansom, BA


• S044: FAS AND FAS LIGAND POLYMORPHISMS AND RISK OF SECOND PRIMARY MALIGNANCY IN PATIENTS WITH INDEX SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. Mark E Zafereo, MD


• S045: TRANSORAL SURGERY USING ROBOTIC SURGICAL SYSTEM FOR HYPOPHARYNGEAL CARCINOMAS: Se-Heon Kim, MD


• S047: TRANSORAL ROBOTIC SURGERY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA: 1 AND 2-YEAR SURVIVAL ANALYSIS: Hilliary N White, MD

FELLOWSHIP INFORMATION SESSION

Jay Boyle, Memorial Sloan-Kettering Cancer Center
Carol Bradford, University of Michigan